<DOC>
	<DOCNO>NCT00449059</DOCNO>
	<brief_summary>The aim study evaluate acute effect nitroglycerine infusion blood pressure heart rate heart-transplanted patient cyclosporine-induced hypertension .</brief_summary>
	<brief_title>Nitrate Hypertension Heart Transplanted Patients</brief_title>
	<detailed_description>Background : Cyclosporine represent milestone immunosuppression organ transplantation . Its use , however , come cost significant side effect , arterial hypertension . Our aim investigate effect acute administration nitroglycerin heart-transplanted patient cyclosporine-induced hypertension . Methods : We include 18 hypertensive patient ( HT ) schedule elective cardiac catheterization heart transplantation treat cyclosporine , well 6-matched HT . Simultaneous measurement BP aorta pulmonary artery administration nitroglycerin do . Results : After injection 50μg 100μg nitroglycerin significant BP decrease observe heart-transplanted patient ( sBP p=0.0001 ; dBP p=0.0001 ) control ( sBP p=0.006 ; dBP p=0.05 ) . This reduction pronounce heart-transplanted patient ( sBP p=0.022 ; dBP 0.018 group comparison ) . 8±3 minute last nitrate infusion BP remain significantly reduce vs baseline heart-transplanted patient ( p &lt; 0.001 ) come back baseline control . The reduction sBP ( p=0.04 50μg nitroglycerin ; p=0.05 100μg nitroglycerin ) dBP correlate cyclosporinemia . Conclusions : This study indicate nitroglycerin reduces sBP heart-transplanted patient cyclosporine-induced hypertension . Further study need evaluate long-term effect nitrate patient .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nitroglycerin</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Hearttransplanted group : Patients hypertension treat cyclosporine Patients optimal standard therapy Patients give write informed consent Control group : Patients hypertension Patients without prior transplantation kind Patients give write informed consent Exclusion criterion : Hypertensive patient receive immunosuppressive drug Patients receive kind nitrate derivates</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>heart transplantation</keyword>
	<keyword>cyclosporine</keyword>
	<keyword>hypertension</keyword>
	<keyword>nitroglycerin</keyword>
</DOC>